Philadelphia, PA — Statement from Daniel J. Hilferty, president and CEO of Independence Health Group, on Gov. Tom Wolf declaring Pennsylvania’s heroin and opioid addiction crisis a statewide disaster emergency….
Philadelphia magazine named Independence President and CEO Daniel J. Hilferty one of the 100 Most Influential People in Philadelphia in the November issue. Hilferty was recognized for Independence’s strong revenue…
Philadelphia, PA — Statement from Daniel J. Hilferty, president and CEO of Independence Health Group, on the company’s 2018 Federal Marketplace participation: “For nearly 80 years, Independence has been serving…

Philadelphia’s premiere rowing event, the Dad Vail Regatta, just became stronger. Independence Blue Cross has become a presenting sponsor of the Dad Vail Regatta and will provide support for this…

Philadelphia – Independence Blue Cross (Independence) and University of Pennsylvania Health System (UPHS) have signed an innovative, five-year contract that strengthens both organizations’ emphasis on coordinated patient care, exchange of…
Company posts revenue and net income gain despite an uncertain health care environment PHILADELPHIA — Independence Health Group, Inc., (Independence) the parent company of Independence Blue Cross, LLC, experienced continued year-over-year…

The Philadelphia chapter of the United Negro College Fund (UNCF) presented its MASKED Award to Independence Blue Cross (Independence) President and CEO Daniel J. Hilferty at its annual Mayor’s Masked…

One-day workshop helps attendees better understand addiction and overdose crisis Drug overdose and opioid-involved deaths continue to rise in the United States. In fact, the 2016 Blue Cross Blue Shield…
Philadelphia, PA — February 27, 2017 — Today health insurance executives met with President Donald Trump, Vice President Mike Pence, and Health and Human Services Secretary Tom Price to discuss…

Independence Blue Cross (Independence) joined local hospitals and medical schools on Friday, February 3, at The Children’s Hospital of Philadelphia to show its support of a new, first-of-its-kind precision medicine…